A

Ascendis Pharma

Biopharmaceutical company developing long-acting prodrugs

Senior Data & Analytics Engineer

Data EngineeringConfirmed live in the last 24 hours
Full-timeHellerup, DenmarkNo salary listed

About the Job

Requirements

  • Hands-on experience with SQL, relational databases, data modelling, and developing data pipelines, transformations, integrations, or reporting solutions.
  • Ability to work across the data and analytics stack, from backend data processing to semantic models and user-facing reporting.
  • Structured approach to testing, documentation, data quality, and change management.
  • Ability to translate business needs into clear, maintainable solutions and collaborate with stakeholders.
  • Strong stakeholder and collaboration skills.

Responsibilities

  • Partner with stakeholders to understand needs, facilitate workshops, and shape fit-for-purpose data and analytics solutions.
  • Design, build, and operate end-to-end solutions, including data pipelines, integrations and transformations, semantic models, dashboards, and reporting.
  • Ensure solutions are reliable, traceable, and well documented, and developed in accordance with data quality, security, governance, and regulatory requirements.
  • Collaborate with colleagues and users to continuously improve solutions, controls, and ways of working.

Desired Qualifications

  • Five or more years of experience within Data & Analytics.
  • Experience with modern data and development tools such as Databricks, dbt, Visual Studio Code, Azure DevOps, Git, and CI/CD.
  • Experience with Power BI.
  • Experience using AI-assisted development tools or coding agents responsibly to support quality and productivity.
  • Understanding of working in a regulated and compliance-focused environment.

About the Company

Ascendis Pharma

Biopharmaceutical company developing long-acting prodrugs

Ascendis Pharma uses its TransCon technology to create long-acting prodrugs for rare endocrine diseases, with expansions into oncology and ophthalmology. The platform temporarily attaches an unmodified drug to an inert carrier and releases the active drug in a predictable, sustained way after injection, reducing how often patients must dosing. It differentiates itself through a proprietary delivery system and a track record that includes marketed therapies like SKYTROFA for pediatric growth hormone deficiency and YORVIPATH for hypoparathyroidism, along with collaborations such as a Novo Nordisk deal. The company aims to improve patient outcomes by enabling easier, less frequent dosing while expanding its pipeline across rare endocrine diseases, cancer, and eye diseases.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Gentofte Municipality, Denmark
Founded
2007

Recently Posted Jobs

Explore more opportunities at Ascendis Pharma

See more jobs